News | Stereotactic Body Radiation Therapy (SBRT) | December 23, 2015

PetCure Oncology's Cancer Treatment Brings Family Pet Home for the Holidays

Five hundred-mile journey from Birmingham to Cincinnati saves Boxer from fatal brain tumor

PetCure Oncology, stereotactic radiosurgery, SRS, Laura Leal, Cincinnati

Pet owner Laura Leal and her beloved Boxer Addy, join Kelli Sloane, radiation therapist, after successful treatment of Addy's brain tumor with stereotactic radiosurgery (SRS) at PetCure Oncology at Care Center in Cincinnati. Photo courtesy of Business Wire

December 23, 2015 — What is the connection between a family in Birmingham, Ala., and a veterinary cancer care team in Cincinnati, Ohio, over 500 miles away? Addy, an 11-year-old Boxer diagnosed with a life-threatening brain tumor, and a dedicated pet owner on a mission to save her furry family member.

With the help of PetCure Oncology at Care Center, pet owner Laura Leal and her beloved Addy will be able to enjoy some extra cheer this holiday season.

Laura and Addy have been an inseparable pair for more than a decade. Laura, a registered nurse, credits her medical training in keeping Addy healthy over the years. This past September, Addy began having seizures. With support and guidance from their Birmingham-based primary-care veterinarian, Addy was referred to a veterinary specialist and a computed tomography (CT) scan was performed.

She was diagnosed with a brain tumor and given weeks or maybe months to live if nothing was done. The recommended treatment was surgery to remove as much of the tumor as possible followed by 30 days of standard radiation therapy (RT). Laura understood the ramifications of the diagnosis but was uncomfortable with the recommendation. Hoping to avoid the lengthy treatment program and undesirable side effects that accompany standard radiation therapy, she wondered if there might be an alternate course of action.

Laura found hope in an emerging new cancer treatment called stereotactic radiosurgery (SRS). She was pointed in the right direction by a friend who had recently attended a lecture that mentioned a study being done on dogs with brain tumors. With that in mind, she began to research the topic online and came across Neal Mauldin, DVM, DACVIM (internal medicine and oncology), DACVR (RO), a leading expert in veterinary SRS and the chief medical officer at PetCure Oncology.

SRS is an advanced form of radiation therapy that has a long history of success in human medicine but has just recently become available to pets suffering from cancer. SRS offers significant benefits over traditional RT by:

  • Offering a treatment with the intent to cure cancer rather than just ease symptoms;
  • Minimizing both the risks and side effects commonly associated with RT;
  • Delivering high doses of radiation with sub-millimeter precision in a non-invasive, non-surgical manner; and
  • Requiring only 1-3 treatment sessions as opposed to 15-30.

“When I read that SRS was non-invasive and completed in 1-3 treatments I knew I had to learn more,” said Laura. “The nearest PetCure Oncology location to me was Cincinnati. I called them the next day and made an appointment.”

In late November, Laura, her father Joe, and Addy made the 8-hour drive from Birmingham to PetCure Oncology at Care Center in Cincinnati. Addy began her SRS treatment on a Wednesday morning and by Thursday afternoon – after just two treatment sessions – they were on the road home.

“Addy did well,” said Laura. “There was no recovery period and no post-treatment wounds. Today she runs around with my sister’s dogs, plays in the backyard and has fun with her toys. The PetCure Oncology team was amazing and willing to help us in every way. This has been a remarkable journey and I know in my heart she has received the best care possible.”

PetCure Oncology has established a network of centers specializing in veterinary SRS across the country. Centers in Phoenix, Cincinnati and Clifton, N.J., are operational. Locations in Wisconsin and Illinois are slated to open in 2016, with many more centers in various stages of development.

For more information: www.petcureoncology.com

Related Content

RayStation Replacing Existing Treatment Planning System at Leeds Cancer Centre
News | Treatment Planning | September 24, 2018
RaySearch recently strengthened its position in the U.K. market with a major order for the treatment planning system...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...